Paolo Paoletti, GammaDelta Therapeutics CEO

Take­da swoops in and scoops up a cell ther­a­py start­up in buy­out deal, ex­pand­ing on­col­o­gy pipeline

A lit­tle more than 4 years af­ter Take­da stepped in to help bankroll the T cell start­up Gam­maDelta Ther­a­peu­tics with a cool $100 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.